ProQR Therapeutics (PRQR) EPS (Basic) (2012 - 2026)

ProQR Therapeutics (PRQR) posted EPS (Basic) of -$0.15 for Q1 2026, down 71.55% sequentially from -$0.09 in Q4 2025, and down 47.69% YoY from -$0.28 in Q1 2025.

ProQR Therapeutics (PRQR) EPS (Basic) (2012 - 2026) Analysis & Trends

ProQR Therapeutics has reported EPS (Basic) for 15 years, with the latest figure at -$0.15 in Q1 2026.

  • Quarterly EPS (Basic) fell 47.69% year-over-year to -$0.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.5 (down 59.91% YoY) and the FY2025 annual result came in at -$0.47, down 35.27% from the prior year.
  • EPS (Basic) fell to -$0.15 in Q1 2026 per PRQR's latest filing, from -$0.09 in the prior quarter.
  • Over five years, EPS (Basic) peaked at -$0.04 in Q2 2024 and troughed at -$0.33 in Q3 2022.
  • A 5-year average of -$0.13 and a median of -$0.11 in 2024 frame the typical range for EPS (Basic).
  • The sharpest annual moves came in 2023 and 2025: EPS (Basic) surged 75.33% in 2023, then tumbled 289.3% in 2025.
  • Over 5 years, EPS (Basic) stood at -$0.19 in 2022, then jumped by 65.38% to -$0.07 in 2023, then sank by 74.28% to -$0.11 in 2024, then gained by 24.13% to -$0.09 in 2025, then sank by 71.55% to -$0.15 in 2026.
  • According to Business Quant data, EPS (Basic) over the past three periods registered -$0.15, -$0.09, and -$0.12 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 ProQR Therapeutics 206.80 Mn 111.86 Mn - -0.15

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.15
Dec 31, 2025 -0.09
Sep 30, 2025 -0.12
Jun 30, 2025 -0.14
Mar 31, 2025 -0.10
Dec 31, 2024 -0.11
Sep 30, 2024 -0.11
Jun 30, 2024 -0.04
Mar 31, 2024 -0.10
Dec 31, 2023 -0.07
Sep 30, 2023 -0.08
Jun 30, 2023 -0.11
Mar 31, 2023 -0.12
Dec 31, 2022 -0.19
Sep 30, 2022 -0.33
Jun 30, 2022 -0.20
Mar 31, 2022 -0.22
Dec 31, 2021 -0.29
Sep 30, 2021 -0.26
Jun 30, 2021 -0.29